Maternal and neonatal outcomes of pregnancy complicated by urolithiasis: a systematic review and meta-analysis

Springer Science and Business Media LLC - Tập 34 - Trang 1569-1580 - 2021
Qin Zhou1,2,3,4,5, Wen-Qing Chen1,2,3,4,5, Xi-Shao Xie1,2,3,4,5, Shi-Long Xiang1,2,3,4,5, Hao Yang1,2,3,4,5, Jiang-Hua Chen1,2,3,4,5
1Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
2Key Laboratory of Nephropathy, Hangzhou, People’s Republic of China
3Kidney Disease Immunology Laboratory, The Third-Grade Laboratory, State Administration of Traditional Chinese Medicine of China, Hangzhou, People’s Republic of China
4Key Laboratory of Multiple Organ Transplantation, Ministry of Health, Hangzhou, People’s Republic of China
5Institute of Nephropathy, Zhejiang University, Hangzhou, People’s Republic of China

Tóm tắt

The effect of urolithiasis on pregnancy-related outcomes remains unknown. The aim of this study was to determine the risk of adverse maternal and neonatal outcomes. We searched PubMed, Embase, and the Cochrane Library through December 2020 for studies reporting on adverse maternal and neonatal outcomes in patients with urolithiasis. Risk ratios (ORs) with 95% confidence intervals (CIs) were calculated for these outcomes in pregnant mothers with urolithiasis and compared to healthy controls. Eight studies comprising 26,577 mothers with urolithiasis were included in our analysis. Preterm birth (OR = 1.63; 95% CI 1.37–1.95, p < 0.001) or very preterm birth risk (OR = 1.49, 95% CI 1.06–2.11, p = 0.02) was more common in patients with urolithiasis compared to healthy controls. Mothers with urolithiasis had an increased incidence of preeclampsia (OR = 1.75, 95% CI 1.33–2.3, p < 0.001), hypertension (OR = 2.97, 95% CI 1.31–6.71, p = 0.009), caesarean section (OR 1.31, 95% CI 1.11–1.55, p = 0.001), and gestational diabetes mellitus (OR 1.84, 95% CI 1.37–2.46, p < 0.001). Patients with urolithiasis may be at increased risk of developing adverse maternal or neonatal outcomes.

Tài liệu tham khảo

Semins MJ, Matlaga BR (2014) Kidney stones during pregnancy. Nat Rev Urol 11:163–168 Semins MJ, Matlaga BR (2010) Management of stone disease in pregnancy. Curr Opin Urol 20:174–177 Kerns E, Lanis A, Onwugbenu N, Bourjeily G (2017) A case report: urolithiasis, hydronephrosis, and acute kidney injury in pregnancy. J Obstet Gynaecol 37:1085–1086 Whittington JR, Simmons PM, Eltahawy EA, Magann EF (2018) Bladder stone in pregnancy: a case report and review of the literature. Am J Case Rep 19:1546–1549 Banhidy F, Acs N, Puho EH, Czeizel AE (2007) Maternal kidney stones during pregnancy and adverse birth outcomes, particularly congenital abnormalities in the offspring. Arch Gynecol Obstet 275:481–487 Swartz MA, Lydon-Rochelle MT, Simon D, Wright JL, Porter MP (2007) Admission for nephrolithiasis in pregnancy and risk of adverse birth outcomes. Obstet Gynecol 109:1099–1104 Rosenberg E, Sergienko R, Abu-Ghanem S, Wiznitzer A, Romanowsky I, Neulander EZ, Sheiner E (2011) Nephrolithiasis during pregnancy: characteristics, complications, and pregnancy outcome. World J Urol 29:743–747 Tangren JS, Powe CE, Ecker J, Bramham K, Ankers E, Karumanchi SA, Thadhani R (2018) Metabolic and hypertensive complications of pregnancy in women with nephrolithiasis. Clin J Am Soc Nephrol 13:612–619 Drescher M, Blackwell RH, Patel PM, Kuo PC, Turk TMT, Baldea KG (2019) Antepartum nephrolithiasis and the risk of preterm delivery. Urolithiasis 47:441–448 Clennon EK, Garg B, Duty BD, Caughey AB (2020) Obstetric outcomes of pregnancy complicated by urolithiasis: a retrospective cohort study. J Perinat Med 218(1):S468 Ordon M, Dirk J, Slater J, Kroft J, Dixon S, Welk B (2020) Incidence, treatment, and implications of kidney stones during pregnancy: a matched population-based cohort study. J Endourol 34:215–221 Sohlberg EM, Brubaker WD, Zhang CA, Anderegg LDL, Dallas KB, Song S, Ganesan C, Chertow GM, Pao AC, Liao JC, Leppert JT, Elliott CS, Conti SL (2020) Urinary stone disease in pregnancy: a claims based analysis of 1.4 million patients. J Urol 203:957–961 Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:208–212 Higgins JP. Cochrane handbook for systematic reviews of interventions version 5.1.0. (2014) The cochrane collaboration. www.cochrane-handbook.org. Accessed 6 Dec 2014 Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558 Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560 Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634 Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I (2006) The case of the misleading funnel plot. BMJ 333:597–600 Body C, Christie JA (2016) Gastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea. Gastroenterol Clin North Am 45:267–283 Kowalewski MP, Kautz E, Högger E, Hoffmann B, Boos A (2014) Interplacental uterine expression of genes involved in prostaglandin synthesis during canine pregnancy and at induced prepartum luteolysis/abortion. Reprod Biol Endocrinol 12:46 Park JY, Romero R, Lee J, Chaemsaithong P, Chaiyasit N, Yoon BH (2016) An elevated amniotic fluid prostaglandin F2α concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes. J Matern Fetal Neonatal Med 29:2563–2572 Pohl O, Chollet A, Kim SH, Riaposova L, Spézia F, Gervais F, Guillaume P, Lluel P, Méen M, Lemaux F, Terzidou V, Bennett PR, Gotteland JP (2018) OBE022, an oral and selective prostaglandin F(2)(α) receptor antagonist as an effective and safe modality for the treatment of preterm labor. J Pharmacol Exp Ther 366:349–364 Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bose CL, Mwapule A, Mwenechanya M, Chomba E, Carlo WA, Chicuy J, Figueroa L, Garces A, Krebs NF, Jessani S, Zehra F, Saleem S, Goldenberg RL, Kurhe K, Das P, Patel A, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Goco N, Hemingway-Foday J, Moore J, Nolen TL, McClure EM, Koso-Thomas M, Miodovnik M, Silver R, Derman RJ (2020) Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet 395:285–293 Brain E, Geraghty RM, Cook P, Roderick P, Somani B (2021) Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years. World J Urol 5:1–7 Elias D, Gimenez L, Poletta F, Campaña H, Gili J, Ratowiecki J, Pawluk M, Rittler M, Santos MR, Uranga R, Heisecke SL, Cosentino V, Saleme C, Gadow E, Krupitzki H, Camelo JSL (2020) Preterm birth and genitourinary tract infections: assessing gene-environment interaction. Pediatr Res 1:1–17 El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7:1409–1415 Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804–811 Vodanović M, Lucijanić M, Zupančić Šalek S, Pećin I (2021) Prevalence of and risk factors for urolithiasis in Croatian patients with hemophilia. Int J Hematol 113(5):656–661 Voerman E, Santos S, Inskip H, Amiano P, Barros H, Charles MA, Chatzi L, Chrousos GP, Corpeleijn E, Crozier S, Doyon M, Eggesbø M, Fantini MP, Farchi S, Forastiere F, Georgiu V, Gori D, Hanke W, Hertz-Picciotto I, Heude B, Hivert MF, Hryhorczuk D, Iñiguez C, Karvonen AM, Küpers LK, Lagström H, Lawlor DA, Lehmann I, Magnus P, Majewska R, Mäkelä J, Manios Y, Mommers M, Morgen CS, Moschonis G, Nohr EA, Nybo Andersen AM, Oken E, Pac A, Papadopoulou E, Pekkanen J, Pizzi C, Polanska K, Porta D, Richiardi L, Rifas-Shiman SL, Roeleveld N, Ronfani L, Santos AC, Standl M, Stigum H, Stoltenberg C, Thiering E, Thijs C, Torrent M, Trnovec T, van Gelder M, van Rossem L, von Berg A, Vrijheid M, Wijga A, Zvinchuk O, Sørensen TIA, Godfrey K, Jaddoe VWV, Gaillard R (2019) Association of gestational weight gain with adverse maternal and infant outcomes. JAMA 321:1702–1715 Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester E (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795–801 Piccoli GB, Attini R, Vasario E, Conijn A, Biolcati M, D’Amico F, Consiglio V, Bontempo S, Todros T (2010) Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol 5:844–855 Piccoli GB, Cabiddu G, Attini R, Vigotti FN, Maxia S, Lepori N, Tuveri M, Massidda M, Marchi C, Mura S, Coscia A, Biolcati M, Gaglioti P, Nichelatti M, Pibiri L, Chessa G, Pani A, Todros T (2015) Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26:2011–2022